0001104659-17-039960.txt : 20170616 0001104659-17-039960.hdr.sgml : 20170616 20170616165709 ACCESSION NUMBER: 0001104659-17-039960 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170614 FILED AS OF DATE: 20170616 DATE AS OF CHANGE: 20170616 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics AG CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: C4 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: LEBERSTRASSE 20 CITY: VIENNA STATE: C4 ZIP: 1110 BUSINESS PHONE: 43 (0)1 740 93-0 MAIL ADDRESS: STREET 1: LEBERSTRASSE 20 CITY: VIENNA STATE: C4 ZIP: 1110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Crotty Robert CENTRAL INDEX KEY: 0001600253 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 FILM NUMBER: 17916748 MAIL ADDRESS: STREET 1: 1301 2ND AVE CITY: SEATTLE STATE: WA ZIP: 98101 3 1 a3.xml 3 X0206 3 2017-06-14 1 0001641640 Nabriva Therapeutics AG NBRV 0001600253 Crotty Robert 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406 0 1 0 0 General Counsel & Corp Sec. No securities are beneficially owned. /s/ Robert Crotty 2017-06-16